JF, W., G, B., TJ, S., G, P., ML, B., & H, Z. (2004). Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/mL) incidental to cystoprostatectomy: Is PSA a useful indicator of clinical significance? Urologic Oncology, 22(1), 40. https://doi.org/10.1016/s1078-1439(03)00093-0
Chicago Style (17th ed.) CitationJF, Ward, Bartsch G, Sebo TJ, Pinggera G, Blute ML, and Zincke H. "Pathologic Characterization of Prostate Cancers with a Very Low Serum Prostate Specific Antigen (0-2 Ng/mL) Incidental to Cystoprostatectomy: Is PSA a Useful Indicator of Clinical Significance?" Urologic Oncology 22, no. 1 (2004): 40. https://doi.org/10.1016/s1078-1439(03)00093-0.
MLA (9th ed.) CitationJF, Ward, et al. "Pathologic Characterization of Prostate Cancers with a Very Low Serum Prostate Specific Antigen (0-2 Ng/mL) Incidental to Cystoprostatectomy: Is PSA a Useful Indicator of Clinical Significance?" Urologic Oncology, vol. 22, no. 1, 2004, p. 40, https://doi.org/10.1016/s1078-1439(03)00093-0.